NCT03578081
Clinical Trial Information
Trial Number: NCT03578081 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
- Miscellaneous Neoplasm - Carcinoma, Miscellaneous
- Miscellaneous Neoplasm - Solid Tumor
Trial Title:
OLANZAPINE WITH OR WITHOUT FOSAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC): A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Study ID:
A221602
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT03578081-D3 | This dataset, NCT03578081-D3-Dataset.csv, is one of 4 datasets associated with PubMed ID 37284847, and contains data related to adverse events. Dataset NCT03578081-D1-Dataset.csv contains data presented in the consort diagram, baseline characteristics table, primary analysis, and supplementary material. Dataset NCT03578081-D2-Dataset.csv contains daily nausea severity scores for patients that continued with the regimen in cycles 2-4. Dataset NCT02116530-D1 associated with this publication contains data from a previous study, A221301, which is presented in Figure 3 and Supplemental Table 2. |
| NCT03578081-D2 | This dataset, NCT03578081-D2-Dataset.csv, is one of 4 datasets associated with PubMed ID 37284847 and contains daily nausea severity scores for patients that continued with the regimen in cycles 2-4. Dataset NCT03578081-D1-Dataset.csv contains data presented in the consort diagram, baseline characteristics table, primary analysis, and supplementary material. Dataset NCT03578081-D3-Dataset.csv contains data related to adverse events. Dataset-NCT02116530-D1 associated with this publication contains data from a previous study, A221301, which is presented in Figure 3 and Supplemental Table 2. |
| NCT03578081-D1 | This dataset, NCT03578081-D1-Dataset.csv, is one of 4 datasets associated with PubMed ID 37284847 and contains data presented in the consort diagram, baseline characteristics table, primary analysis, and supplementary material. Dataset NCT03578081-D2-Dataset.csv contains daily nausea severity scores for patients that continued with the regimen in cycles 2-4. Dataset NCT03578081-D3-Dataset.csv contains data related to adverse events. Dataset NCT02116530-D1 associated with this publication contains data from a previous study, A221301, which is presented in Figure 3 and Supplemental Table 2. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®